NEW YORK (TheStreet) -- Henry Schein (HSIC) shares are up 2.51% to $142.32 after the healthcare product provider reported its first quarter financial results before the opening bell today.
The Melville, NY-based company reported a first quarter net profit of $103.4 million, or $1.28 per diluted share, on revenue that rose 1.4% year over year to $2.46 billion. Analysts on average were expecting the company to report earnings of $1.27 per share on revenue of $2.54 billion.
The company's dental segment lagged during the quarter with revenue falling 3.6% year over year to $1.25 billion, though its animal health segment rose 4.6% to $684.3 million.
For the year the company reaffirmed its full year guidance between $5.90 and $6, the midpoint of which is ahead of the $5.92 analysts are expecting the company to earn.
TheStreet Ratings team rates SCHEIN (HENRY) INC as a Buy with a ratings score of A. TheStreet Ratings Team has this to say about their recommendation:
"We rate SCHEIN (HENRY) INC (HSIC) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth, notable return on equity, solid stock price performance and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow."